Bio-Rad Reports First-Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Bio-Rad Labs (BIO) Tops Q1 EPS by $2.21
April 29, 2021 4:18 PM EDTBio-Rad Labs (NYSE: BIO) reported Q1 EPS of $5.21, $2.21 better than the analyst estimate of $3.00. Revenue for the quarter came in at $726.8 million versus the consensus estimate of $660.98 million.
2021 Financial Outlook
For the full year 2021, the company has updated its guidance and now anticipates non-GAAP... More
